Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In FDA Actions
FDA Actions for May/June 2017
FDA Approves Drug to Treat ALS, FDA news release; 2017 May 5
FDA Approves RoxyBond for Severe Pain, Inspirion Delivery Sciences, LLC news release; 2017 Apr 26
FDA Approves First Treatment for Batten Disease Type , FDA news release; 2017 April 27
FDA Actions for March/April 2017
FDA Approves First Drug for Tardive Dyskinesia, FDA news release; 2017 Apr 11
FDA Approves First Drug for Tardive Dyskinesia, FDA news release; 2017 Apr 11
Expanded FDA Approval for Trokendi XR, Supernus news release; 2017 Apr 5
Austedo Approved to Treat Chorea in Huntington's Disease, Teva news release; 2017 Apr 3
FDA Approves New Add-On Treatment for Parkinson's, FDA news release; 2017 Mar 21
FDA Actions for January/February 2017
FDA Approves Drug to Treat Duchenne MD, FDA news release; 2017 Feb 9
FDA Approves Narcan Nasal Spray 2mg , Adapt Pharma news release; 2017 Jan 25
FDA Approves Arymo ER for Severe Pain, Egalet news release; 2017 Jan 9
FDA Approves Spinraza, First Drug for SMA , FDA news release, 2016 Dec 23
FDA Actions for November/December 2016
FDA Approves Expanded Use for Stent Retriever, Medtronic news release; 2016 Nov 16
FDA Approves Recurrent Stroke Prevention Device, FDA news release; 2016 Oct 28
FDA Approves Carnexiv Injection for Seizures, H. Lundbeck A/S news release; 2016 Oct 8
FDA Actions for September/October 2016
New Dosage Strengths Available for Alzheimer Drug, Allergan plc news release; 2016 Sep 22
FDA Grants Approval for First Drug for Duchenne MD, Sarepta Therapeutics news release; 2016 Sep 19